Sotera Health plans to announce Q1 2026 financial results on May 5, followed by a conference call.
Quiver AI Summary
Sotera Health Company announced that it will release its financial results for the first quarter ending March 31, 2026, before the market opens on May 5, 2026. Following the announcement, management will hold a conference call at 9:00 a.m. Eastern Daylight Time to discuss the results, which will be accessible through a live webcast on the company's Investor Relations website. A recording of the call will be available later the same day. Sotera Health specializes in sterilization solutions, lab testing, and advisory services for the healthcare industry with three distinct businesses: Sterigenics, Nordion, and Nelson Labs, emphasizing its commitment to global health.
Potential Positives
- Sotera Health is demonstrating transparency and commitment to stakeholder communication by scheduling a conference call to discuss its financial results, indicating healthy investor relations.
- The announcement of upcoming financial results may generate positive market reactions and investor interest, potentially enhancing the company's reputation and stock performance.
- Providing access to a live webcast of the conference call showcases the company's dedication to accessibility and modern communication practices.
Potential Negatives
- Management's decision to announce financial results before the market opens could indicate potential concerns about the results, as companies typically choose to release results at market close to allow for full analysis by investors.
- The choice to host a conference call may be seen as an attempt to manage investor sentiment, which could imply previous challenges or dissatisfaction with the company's performance that necessitate direct communication.
- There is a specific mention of updates related to Ethylene Oxide, which suggests ongoing regulatory or safety concerns affecting the company, potentially alarming stakeholders.
FAQ
When will Sotera Health release its Q1 2026 financial results?
Sotera Health will release its financial results on May 5, 2026, before the market opens.
What time is the conference call for discussing financial results?
The conference call will take place at 9:00 a.m. Eastern Daylight Time on May 5, 2026.
How can I access the conference call webcast?
The webcast can be accessed via the Investor Relations section of Sotera Health's website.
Will there be a replay of the conference call available?
Yes, a replay of the conference call webcast will be available later in the day on May 5, 2026.
Where can I find updates on Sotera Health's investor relations?
Updates on investor relations can be found in the Investor Relations section of the Sotera Health website.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$SHC Insider Trading Activity
$SHC insiders have traded $SHC stock on the open market 12 times in the past 6 months. Of those trades, 0 have been purchases and 12 have been sales.
Here’s a breakdown of recent trading of $SHC stock by insiders over the last 6 months:
- PINCUS & CO. WARBURG has made 0 purchases and 6 sales selling 85,440,000 shares for an estimated $1,338,991,200.
- INVESTMENT XI LLC GTCR has made 0 purchases and 3 sales selling 28,480,000 shares for an estimated $446,330,400.
- MICHAEL B. JR. PETRAS (Chairman & CEO) has made 0 purchases and 3 sales selling 750,000 shares for an estimated $12,337,499.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$SHC Revenue
$SHC had revenues of $303.4M in Q4 2025. This is an increase of 4.56% from the same period in the prior year.
You can track SHC financials on Quiver Quantitative's SHC stock page.
$SHC Hedge Fund Activity
We have seen 203 institutional investors add shares of $SHC stock to their portfolio, and 80 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- WARBURG PINCUS LLC removed 27,720,000 shares (-44.8%) from their portfolio in Q4 2025, for an estimated $488,980,800
- GTCR LLC removed 18,480,000 shares (-44.8%) from their portfolio in Q4 2025, for an estimated $325,987,200
- SESSA CAPITAL IM, L.P. added 10,630,381 shares (+107.2%) to their portfolio in Q4 2025, for an estimated $187,519,920
- SCULPTOR CAPITAL LP added 7,658,200 shares (+57.4%) to their portfolio in Q4 2025, for an estimated $135,090,648
- T. ROWE PRICE INVESTMENT MANAGEMENT, INC. removed 7,546,051 shares (-81.9%) from their portfolio in Q4 2025, for an estimated $133,112,339
- SACHEM HEAD CAPITAL MANAGEMENT LP added 3,735,000 shares (+47.2%) to their portfolio in Q4 2025, for an estimated $65,885,400
- VOSS CAPITAL, LP added 3,208,482 shares (+427.8%) to their portfolio in Q4 2025, for an estimated $56,597,622
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$SHC Analyst Ratings
Wall Street analysts have issued reports on $SHC in the last several months. We have seen 4 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Citigroup issued a "Buy" rating on 02/24/2026
- RBC Capital issued a "Outperform" rating on 01/09/2026
- William Blair issued a "Outperform" rating on 12/18/2025
- BMO Capital issued a "Outperform" rating on 11/13/2025
To track analyst ratings and price targets for $SHC, check out Quiver Quantitative's $SHC forecast page.
$SHC Price Targets
Multiple analysts have issued price targets for $SHC recently. We have seen 6 analysts offer price targets for $SHC in the last 6 months, with a median target of $21.0.
Here are some recent targets:
- Luke Sergott from Barclays set a target price of $18.0 on 04/14/2026
- Patrick Donnelly from Citigroup set a target price of $23.0 on 02/24/2026
- Jason Bednar from Piper Sandler set a target price of $24.0 on 01/09/2026
- Sean Dodge from RBC Capital set a target price of $24.0 on 01/09/2026
- Sean Dodge from BMO Capital set a target price of $19.0 on 11/13/2025
- Casey Woodring from JP Morgan set a target price of $16.0 on 11/05/2025
Full Release
CLEVELAND, April 21, 2026 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions, lab testing and advisory services for the healthcare industry, today announced its plans to release its financial results for the first-quarter ended March 31, 2026 before the market opens on Tuesday, May 5, 2026. Following the release, management will host a conference call at 9:00 a.m. Eastern Daylight Time to discuss the Company’s operating and financial results.
A live webcast of the conference call and accompanying materials can be accessed via the Investor Relations section of the Company’s website at Presentation & Events | Sotera Health . A replay of the webcast will be available later in the day on May 5.
Updates can be found from time to time on recent developments in matters relevant to investors on the Investor Relations section of the Company’s website at Investor Relations | Sotera Health . For developments related to Ethylene Oxide, updates can be found at Ethylene Oxide | Sotera Health .
About Sotera Health
Sotera Health Company is a leading global provider of mission-critical end-to-end sterilization solutions, lab testing and advisory services for the healthcare industry. Sotera Health goes to market through three businesses – Sterigenics®, Nordion® and Nelson Labs®. Sotera Health is committed to its mission, Safeguarding Global Health®.
| Contacts |
|
Jason Peterson
Vice President, Investor Relations [email protected] |
|
Kristin Gibbs
Chief Marketing Officer, Sotera Health [email protected] |
Source: Sotera Health Company
